During clinical trials the overall rates of hypoglycaemia did not differ between patients treated with insulin aspart compared to human insulin.
Kliinilistes uuringutes ei ole leitud erinevusi hüpoglükeemia esinemises aspartinsuliini ja humaaninsuliiniga ravitud patsientidel.